Cargando…

A Reference Laboratory Surveillance on Fungal Isolates from Patients with Haematological Malignancy in Japan

Invasive fungal disease (IFD) in patients with haematological disorders is a fatal disease, making rapid identification and treatment crucial. However, the identification of the causative fungus is often difficult, sometimes even impossible. There have been few reports concerning the causative speci...

Descripción completa

Detalles Bibliográficos
Autores principales: Hino, Yutaro, Watanabe, Akira, Seki, Rio, Tsukamoto, Shokichi, Takeda, Yusuke, Sakaida, Emiko, Kamei, Katsuhiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8537693/
https://www.ncbi.nlm.nih.gov/pubmed/34682228
http://dx.doi.org/10.3390/jof7100806
_version_ 1784588322694234112
author Hino, Yutaro
Watanabe, Akira
Seki, Rio
Tsukamoto, Shokichi
Takeda, Yusuke
Sakaida, Emiko
Kamei, Katsuhiko
author_facet Hino, Yutaro
Watanabe, Akira
Seki, Rio
Tsukamoto, Shokichi
Takeda, Yusuke
Sakaida, Emiko
Kamei, Katsuhiko
author_sort Hino, Yutaro
collection PubMed
description Invasive fungal disease (IFD) in patients with haematological disorders is a fatal disease, making rapid identification and treatment crucial. However, the identification of the causative fungus is often difficult, sometimes even impossible. There have been few reports concerning the causative species of IFD. This study aimed to investigate the epidemiology and causative organism of IFD in patients with haematological diseases in Japan. We analyzed the IFD cases among the patients with haematological malignancies identified at the Medical Mycological Research Center, Chiba University, between 2013 and 2019. The most common underlying disease was acute myeloid leukaemia (34.3%). Forty-six point one percent of IFD patients received haematopoietic stem cell transplantation (HSCT). The major pathogens were Aspergillus, Candida, and Fusarium. Aspergillus fumigatus was the most common Aspergillus species, and Candida fermentati and Fusarium petroliphilum were the most common Candida and Fusarium species, respectively, in this analysis. Furthermore, various cryptic species and non-albicans Candida were identified. The drug susceptibility of such relatively rare strains suggests that analysis of the causative fungi should provide valuable information for therapeutic options. Therefore, our study indicated that it is clinically significant to identify the organism in as much detail as possible.
format Online
Article
Text
id pubmed-8537693
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-85376932021-10-24 A Reference Laboratory Surveillance on Fungal Isolates from Patients with Haematological Malignancy in Japan Hino, Yutaro Watanabe, Akira Seki, Rio Tsukamoto, Shokichi Takeda, Yusuke Sakaida, Emiko Kamei, Katsuhiko J Fungi (Basel) Article Invasive fungal disease (IFD) in patients with haematological disorders is a fatal disease, making rapid identification and treatment crucial. However, the identification of the causative fungus is often difficult, sometimes even impossible. There have been few reports concerning the causative species of IFD. This study aimed to investigate the epidemiology and causative organism of IFD in patients with haematological diseases in Japan. We analyzed the IFD cases among the patients with haematological malignancies identified at the Medical Mycological Research Center, Chiba University, between 2013 and 2019. The most common underlying disease was acute myeloid leukaemia (34.3%). Forty-six point one percent of IFD patients received haematopoietic stem cell transplantation (HSCT). The major pathogens were Aspergillus, Candida, and Fusarium. Aspergillus fumigatus was the most common Aspergillus species, and Candida fermentati and Fusarium petroliphilum were the most common Candida and Fusarium species, respectively, in this analysis. Furthermore, various cryptic species and non-albicans Candida were identified. The drug susceptibility of such relatively rare strains suggests that analysis of the causative fungi should provide valuable information for therapeutic options. Therefore, our study indicated that it is clinically significant to identify the organism in as much detail as possible. MDPI 2021-09-27 /pmc/articles/PMC8537693/ /pubmed/34682228 http://dx.doi.org/10.3390/jof7100806 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Hino, Yutaro
Watanabe, Akira
Seki, Rio
Tsukamoto, Shokichi
Takeda, Yusuke
Sakaida, Emiko
Kamei, Katsuhiko
A Reference Laboratory Surveillance on Fungal Isolates from Patients with Haematological Malignancy in Japan
title A Reference Laboratory Surveillance on Fungal Isolates from Patients with Haematological Malignancy in Japan
title_full A Reference Laboratory Surveillance on Fungal Isolates from Patients with Haematological Malignancy in Japan
title_fullStr A Reference Laboratory Surveillance on Fungal Isolates from Patients with Haematological Malignancy in Japan
title_full_unstemmed A Reference Laboratory Surveillance on Fungal Isolates from Patients with Haematological Malignancy in Japan
title_short A Reference Laboratory Surveillance on Fungal Isolates from Patients with Haematological Malignancy in Japan
title_sort reference laboratory surveillance on fungal isolates from patients with haematological malignancy in japan
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8537693/
https://www.ncbi.nlm.nih.gov/pubmed/34682228
http://dx.doi.org/10.3390/jof7100806
work_keys_str_mv AT hinoyutaro areferencelaboratorysurveillanceonfungalisolatesfrompatientswithhaematologicalmalignancyinjapan
AT watanabeakira areferencelaboratorysurveillanceonfungalisolatesfrompatientswithhaematologicalmalignancyinjapan
AT sekirio areferencelaboratorysurveillanceonfungalisolatesfrompatientswithhaematologicalmalignancyinjapan
AT tsukamotoshokichi areferencelaboratorysurveillanceonfungalisolatesfrompatientswithhaematologicalmalignancyinjapan
AT takedayusuke areferencelaboratorysurveillanceonfungalisolatesfrompatientswithhaematologicalmalignancyinjapan
AT sakaidaemiko areferencelaboratorysurveillanceonfungalisolatesfrompatientswithhaematologicalmalignancyinjapan
AT kameikatsuhiko areferencelaboratorysurveillanceonfungalisolatesfrompatientswithhaematologicalmalignancyinjapan
AT hinoyutaro referencelaboratorysurveillanceonfungalisolatesfrompatientswithhaematologicalmalignancyinjapan
AT watanabeakira referencelaboratorysurveillanceonfungalisolatesfrompatientswithhaematologicalmalignancyinjapan
AT sekirio referencelaboratorysurveillanceonfungalisolatesfrompatientswithhaematologicalmalignancyinjapan
AT tsukamotoshokichi referencelaboratorysurveillanceonfungalisolatesfrompatientswithhaematologicalmalignancyinjapan
AT takedayusuke referencelaboratorysurveillanceonfungalisolatesfrompatientswithhaematologicalmalignancyinjapan
AT sakaidaemiko referencelaboratorysurveillanceonfungalisolatesfrompatientswithhaematologicalmalignancyinjapan
AT kameikatsuhiko referencelaboratorysurveillanceonfungalisolatesfrompatientswithhaematologicalmalignancyinjapan